142 related articles for article (PubMed ID: 18553462)
1. Nicotinamide N-methyl transferase (NNMT) gene polymorphisms and risk for spina bifida.
Lu W; Zhu H; Wen S; Yang W; Shaw GM; Lammer EJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2008 Oct; 82(10):670-5. PubMed ID: 18553462
[TBL] [Abstract][Full Text] [Related]
2. Screening for novel PAX3 polymorphisms and risks of spina bifida.
Lu W; Zhu H; Wen S; Laurent C; Shaw GM; Lammer EJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2007 Jan; 79(1):45-9. PubMed ID: 17149730
[TBL] [Abstract][Full Text] [Related]
3. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects.
Shaw GM; Lu W; Zhu H; Yang W; Briggs FB; Carmichael SL; Barcellos LF; Lammer EJ; Finnell RH
BMC Med Genet; 2009 Jun; 10():49. PubMed ID: 19493349
[TBL] [Abstract][Full Text] [Related]
4. CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population.
Enaw JO; Zhu H; Yang W; Lu W; Shaw GM; Lammer EJ; Finnell RH
BMC Med; 2006 Dec; 4():36. PubMed ID: 17184542
[TBL] [Abstract][Full Text] [Related]
5. Genes encoding critical transcriptional activators for murine neural tube development and human spina bifida: a case-control study.
Lu W; Guzman AR; Yang W; Chapa CJ; Shaw GM; Greene RM; Pisano MM; Lammer EJ; Finnell RH; Zhu H
BMC Med Genet; 2010 Oct; 11():141. PubMed ID: 20932315
[TBL] [Abstract][Full Text] [Related]
6. Association between CFL1 gene polymorphisms and spina bifida risk in a California population.
Zhu H; Enaw JO; Ma C; Shaw GM; Lammer EJ; Finnell RH
BMC Med Genet; 2007 Mar; 8():12. PubMed ID: 17352815
[TBL] [Abstract][Full Text] [Related]
7. Genes encoding catalytic subunits of protein kinase A and risk of spina bifida.
Zhu H; Lu W; Laurent C; Shaw GM; Lammer EJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):591-6. PubMed ID: 16080189
[TBL] [Abstract][Full Text] [Related]
8. Heme oxygenase-1 promoter polymorphisms and risk of spina bifida.
Fujioka K; Yang W; Wallenstein MB; Zhao H; Wong RJ; Stevenson DK; Shaw GM
Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):741-6. PubMed ID: 26173399
[TBL] [Abstract][Full Text] [Related]
9. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida.
Shaw GM; Rozen R; Finnell RH; Wasserman CR; Lammer EJ
Am J Epidemiol; 1998 Jul; 148(1):30-7. PubMed ID: 9663401
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population.
Carter TC; Pangilinan F; Troendle JF; Molloy AM; VanderMeer J; Mitchell A; Kirke PN; Conley MR; Shane B; Scott JM; Brody LC; Mills JL
Am J Med Genet A; 2011 Jan; 155A(1):14-21. PubMed ID: 21204206
[TBL] [Abstract][Full Text] [Related]
11. Microsatellites proximal to leptin and leptin receptor as risk factors for spina bifida.
Shaw GM; Barber R; Todoroff K; Lammer EJ; Finnell RH
Teratology; 2000 Mar; 61(3):231-5. PubMed ID: 10661913
[TBL] [Abstract][Full Text] [Related]
12. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida.
Shaw GM; Lammer EJ; Zhu H; Baker MW; Neri E; Finnell RH
Am J Med Genet; 2002 Feb; 108(1):1-6. PubMed ID: 11857541
[TBL] [Abstract][Full Text] [Related]
13. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy.
de Franchis R; Buoninconti A; Mandato C; Pepe A; Sperandeo MP; Del Gado R; Capra V; Salvaggio E; Andria G; Mastroiacovo P
J Med Genet; 1998 Dec; 35(12):1009-13. PubMed ID: 9863598
[TBL] [Abstract][Full Text] [Related]
14. Are the betaine-homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts?
Zhu H; Curry S; Wen S; Wicker NJ; Shaw GM; Lammer EJ; Yang W; Jafarov T; Finnell RH
Am J Med Genet A; 2005 Jun; 135(3):274-7. PubMed ID: 15887275
[TBL] [Abstract][Full Text] [Related]
15. An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1).
Franke B; Vermeulen SH; Steegers-Theunissen RP; Coenen MJ; Schijvenaars MM; Scheffer H; den Heijer M; Blom HJ
Birth Defects Res A Clin Mol Teratol; 2009 Mar; 85(3):216-26. PubMed ID: 19161160
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation aberrations rather than polymorphisms of FZD3 gene increase the risk of spina bifida in a high-risk region for neural tube defects.
Shangguan S; Wang L; Chang S; Lu X; Wang Z; Wu L; Wang J; Wang X; Guan Z; Bao Y; Zhao H; Zou J; Niu B; Zhang T
Birth Defects Res A Clin Mol Teratol; 2015 Jan; 103(1):37-44. PubMed ID: 25131656
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylethanolamine N-methyltransferase (PEMT) gene polymorphisms and risk of spina bifida.
Zhang J; Zhu H; Yang W; Shaw GM; Lammer EJ; Finnell RH
Am J Med Genet A; 2006 Apr; 140(7):785-9. PubMed ID: 16523512
[No Abstract] [Full Text] [Related]
18. Risk factors for neural tube defects: associations between uncoupling protein 2 polymorphisms and spina bifida.
Volcik KA; Shaw GM; Zhu H; Lammer EJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):158-61. PubMed ID: 12797456
[TBL] [Abstract][Full Text] [Related]
19. Loss of function polymorphisms in NAT1 protect against spina bifida.
Jensen LE; Hoess K; Mitchell LE; Whitehead AS
Hum Genet; 2006 Aug; 120(1):52-7. PubMed ID: 16680433
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.
Volcik KA; Shaw GM; Lammer EJ; Zhu H; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):154-7. PubMed ID: 12797455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
